Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Sales | 54,549 | 76,987 | 38,627 | 29,750 | 17,820 |
| Gross Profit | 54,549 | 76,987 | 38,627 | 29,750 | 17,820 |
| Operating Expenses | 267,576 | 232,050 | 222,494 | 147,636 | 82,803 |
| Operating Income | -213,027 | -155,063 | -183,867 | -117,886 | -64,983 |
| Other Income | 19,728 | 11,115 | 3,507 | 823 | 1,206 |
| Pre-tax Income | -193,299 | -143,948 | -180,360 | -117,063 | -63,777 |
| Income Tax | 270 | N/A | N/A | 131 | -20,535 |
| Net Income Continuous | -193,569 | -143,948 | -180,360 | -117,194 | -43,242 |
| Net Income | $-193,569 | $-143,948 | $-180,360 | $-117,194 | $-43,242 |
| EPS Basic Total Ops | -2.88 | -2.65 | -3.71 | -2.73 | -2.76 |
| EPS Basic Continuous Ops | -2.88 | -2.65 | -3.71 | -2.73 | -2.76 |
| EPS Diluted Total Ops | -2.88 | -2.65 | -3.71 | -2.73 | -2.76 |
| EPS Diluted Continuous Ops | -2.88 | -2.65 | -3.71 | -2.73 | -2.76 |
| EPS Diluted Before Non-Recurring Items | -2.88 | -2.65 | -3.71 | -2.73 | -2.76 |
| EBITDA(a) | $-207,887 | $-146,830 | $-172,633 | $-110,098 | $-62,530 |